Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Archemix
Archemix
Baxter Announces Acquisition of All Hemophilia-Related Assets of Archemix and an Exclusive License of Its Anti-TFPI Aptamer Technology
Fri, 11/19/10 - 03:00 pm
Baxter International
Archemix
hemophilia
Anti-TFPI Aptamer Technology
GlaxoSmithKline working with Archemix
The Hindu, India
Wed, 12/24/08 - 10:39 am
GSK
Archemix
Glaxo, Archemix in $1.4 Billion Arthritis Drugs Deal
Bloomberg
Tue, 12/23/08 - 12:25 pm
GSK
arthritis
Archemix